by Madhumathi Palaniappan on February 20, 2017 at 10:28 PM Health Watch Highlights Multiple sclerosis is a central nervous system disorder which affects the brain and spinal cord. Resetting the immune system by Autologous Hematopoietic Stem Cell ... Med India, 1 week ago
MicroRNAs - Promising Biomarkers for Monitoring Progression of Multiple Sclerosis - Med India, 1 month ago
Alemtuzumab drug prescribed for the treatment of multiple sclerosis was found to trigger unpredictable side effects in patients, reveals study.Med India, 1 month ago Ocrelizumab Drug For Multiple Sclerosis Treatment Med India, 1 month ago Ocrelizumab Drug Shows Promising Results for the Treatment of Multiple Sclerosis Med India, 1 month ago
Israel - based generic drugmaker Teva Pharmaceutical Industries Ltd said on Monday that Chief Executive Erez Vigodman was stepping down effective immediately and would be replaced on an interim basis by Yitzhak Peterburg, who has been chairman of Teva's board ...Sify, 2 weeks ago
(Reuters) - Biogen Inc said on Tuesday it would pay Forward Pharma A/S $1.25 billion to license the Danish company's patents covering multiple sclerosis drugs, providing Biogen an insurance policy on future sales of Tecfidera, its blockbuster oral treatment ...Reuters, 1 month ago
(Reuters) - Shares in Swiss biopharmaceuticals company Actelion surged more than 8 percent to a record high after Bloomberg reported that talks with French suitor Sanofi were nearing an agreement that could be worth about $275 per share. The potential deal, ...Sify, 2 months ago
By Carl O'Donnell (Reuters) - U.S. President-elect Donald Trump's plan to incentivize U.S. companies to repatriate their swelling overseas cash piles could spur a new wave of dealmaking in a pharmaceutical industry seeking to buy its way into growth. For ...Sify, 2 months ago
on your WebpageAdd Widget >Get your members hooked!